GGrantIndex
← Leaderboards

Richard Samuel Hotchkiss

Washington University

$18,878,445
Attributed
$20,089,679
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,089,679 · 9

By mechanism

R01$9,937,944 · 4
R37$5,126,124 · 1
R35$4,110,171 · 1
R21$406,600 · 1
T32$350,451 · 1
R34$158,389 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Sepsis

Research focus

SepsisApoptosisInfectionCessation Of LifeCytokineImmune SystemFunctional DisorderImmuneIntensive Care UnitsT-LymphocyteLymphocyteSepticAnimal ModelPathogenUnited StatesNatural ImmunosuppressionSpleenBloodCause Of DeathCellsApoptoticPreventLaboratoriesImmunosuppression

Grant awards (51)

Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$575,370
R35 · FY2025 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$575,370
R35 · FY2024 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$576,604
R35 · FY2023 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$495,627
R35 · FY2022 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$495,627
R35 · FY2021 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$495,627
R35 · FY2020 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$495,627
R35 · FY2019 · GM · contact PI
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival$400,319
R35 · FY2018 · GM · contact PI
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$381,250
R01 · FY2017 · GM · contact PI
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$381,250
R01 · FY2016 · GM · contact PI
MECHANISMS OF IMMUNOSUPPRESSION IN SEPSIS$540,965
R01 · FY2015 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$381,250
R01 · FY2015 · GM · contact PI
Immunotherapy of sepsis using anti-PDL1 antibody$158,389
R34 · FY2015 · GM
MECHANISMS OF IMMUNOSUPPRESSION IN SEPSIS$552,193
R01 · FY2014 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$381,250
R01 · FY2014 · GM · contact PI
MECHANISMS OF IMMUNOSUPPRESSION IN SEPSIS$544,546
R01 · FY2013 · GM
IMMUNOSUPPRESSION IN SEPSIS DETECTED BY REACTIVATION OF LATENT VIRUSES$178,600
R21 · FY2013 · AI · contact PI
MECHANISMS OF IMMUNOSUPPRESSION IN SEPSIS$573,579
R01 · FY2012 · GM
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE$491,400
R01 · FY2012 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$469,241
R37 · FY2012 · GM · contact PI
IMMUNOSUPPRESSION IN SEPSIS DETECTED BY REACTIVATION OF LATENT VIRUSES$228,000
R21 · FY2012 · AI · contact PI
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE$491,399
R01 · FY2011 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$469,241
R37 · FY2011 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$479,058
R37 · FY2010 · GM · contact PI
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE$373,627
R01 · FY2010 · GM · contact PI
Postdoctoral Training Program in Critical Care$175,964
T32 · FY2010 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$578,831
R37 · FY2009 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$474,933
R37 · FY2009 · GM · contact PI
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE$367,857
R01 · FY2009 · GM · contact PI
Postdoctoral Training Program in Critical Care$174,487
T32 · FY2009 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$462,016
R37 · FY2008 · GM · contact PI
Cellular Mechanisms of Sepsis and Organ Failure$326,412
R01 · FY2008 · GM · contact PI
Cellular Injury and Adaptation$311,905
R01 · FY2008 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$438,417
R37 · FY2007 · GM · contact PI
Cellular Mechanisms of Sepsis and Organ Failure$400,329
R01 · FY2007 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$442,925
R37 · FY2006 · GM · contact PI
Cellular Mechanisms of Sepsis and Organ Failure$336,161
R01 · FY2006 · GM · contact PI
Cellular Mechanisms of Sepsis and Organ Failure$72,131
R01 · FY2006 · GM · contact PI
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$441,489
R37 · FY2005 · GM
Cellular Mechanisms of Sepsis and Organ Failure$344,250
R01 · FY2005 · GM
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$428,697
R37 · FY2004 · GM
Cellular Mechanisms of Sepsis and Organ Failure$331,100
R01 · FY2004 · GM
Prevention of Apoptotic Cell Death in Sepsis by BCL-2$441,276
R37 · FY2003 · GM
Cellular Mechanisms of Sepsis and Organ Failure$331,100
R01 · FY2003 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$373,244
R01 · FY2002 · GM
Cellular Mechanisms of Sepsis and Organ Failure$331,100
R01 · FY2002 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$366,180
R01 · FY2001 · GM
Cellular Mechanisms of Sepsis and Organ Failure$331,100
R01 · FY2001 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$74,140
R01 · FY2001 · GM
PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2$358,859
R01 · FY2000 · GM
CELLULAR MECHANISMS OF SEPSIS AND ORGAN FAILURE$189,367
R01 · FY2000 · GM